Boston reported second-quarter results that included revenue of $5.44 billion (up 7% operationally) and net income of $905 million (up 14% year over year), along with a lower outlook for the full year.
Boston remains one of the top players when it comes to intellectual property in medtech, which bodes well for its ability to innovate enough to keep up with rivals.
Boston's coronary stent business is less moaty than its cardiac rhythm management segment.
|
Metric
|
BSX
|
ABT
|
JNJ
|
|---|---|---|---|
Price/Earnings (Normalized) | 15.36 | 20.49 | 23.87 |
Price/Book Value | 2.86 | 3.65 | 7.35 |
Price/Sales | 3.50 | 4.04 | 6.46 |
Price/Cash Flow | 14.22 | 17.22 | 22.12 |
|
Metric
|
BSX
|
ABT
|
JNJ
|
|---|---|---|---|
Quick Ratio | 0.56 | 0.97 | 0.73 |
Current Ratio | 1.24 | 1.38 | 1.09 |
Interest Coverage | 11.56 | 10.40 | 25.00 |
|
Metric
|
BSX
|
ABT
|
JNJ
|
|---|---|---|---|
Return on Assets (Normalized) | 11.01% | 9.71% | 13.42% |
Return on Equity (Normalized) | 19.82% | 17.95% | 32.69% |
Return on Invested Capital (Normalized) | 14.09% | 13.03% | 20.33% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|#cJK&!N | LOCK|rS$LP | $187B | |||
| Stryker Corp
SYK
| LOCK|%$%Lxk@s | LOCK|&v | $130B | |||
| Medtronic PLC
MDT
| LOCK|GGBvdsD | LOCK|nvlL | $112B | |||
| Edwards Lifesciences Corp
EW
| LOCK|!stVg^G^ | LOCK|Tp^> | $52B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|?C>P@@ | LOCK|wH | $32B | |||
| DexCom Inc
DXCM
| LOCK|GJ?Q<#d! | LOCK|^q?R< | $32B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|$> | LOCK|%!k | $26B | |||
| Steris PLC
STE
| LOCK|Q<@sY@< | LOCK|C@JC | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|%Z#%tB#y | LOCK|xM | $18B |
/author-service-images-prod-us-east-1.publishing.aws.arc.pub/morningstar/adf521c2-d9af-477d-a6bc-03ec7ca34c40.jpg)
United States